[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@BioCentury](/creator/twitter/BioCentury)
"Novartis names Mehta new CFO. Plus: Biontechs chief strategy officer steps down and updates from Vor Vivid Dx in BioCentury's Management Tracks"  
![@BioCentury Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::227778014.png) [@BioCentury](/creator/x/BioCentury) on [X](/post/tweet/1946012088293371953) 2025-07-18 01:00:11 UTC 16.2K followers, XXX engagements


"Rare disease setbacks for Ultragenyx mid-stage win for Rhythm. Plus: Astrazeneca and Takeda preparing submissions after Phase III readouts in this weeks Clinical Report"  
![@BioCentury Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::227778014.png) [@BioCentury](/creator/x/BioCentury) on [X](/post/tweet/1945249566049095747) 2025-07-15 22:30:12 UTC 16.2K followers, XXX engagements


"Capital flows continue in Asia. Ascentage Pharma raises $192M in Hong Kong placement while Korea-based Illimis raises $XX million in a series B round: BioCentury's latest Finance Report"  
![@BioCentury Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::227778014.png) [@BioCentury](/creator/x/BioCentury) on [X](/post/tweet/1946321633376944468) 2025-07-18 21:30:12 UTC 16.2K followers, XXX engagements


"Third patient dies from acute liver failure caused by a Sarepta gene therapy"  
![@BioCentury Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::227778014.png) [@BioCentury](/creator/x/BioCentury) on [X](/post/tweet/1945996977247793589) 2025-07-18 00:00:08 UTC 16.2K followers, 90.7K engagements


"Lundbeckfondens Jacob Falck Hansen becomes CEO of portfolio company Vesper Bio. Also in BioCentury's Management Moves Column:Oncolytics reunitesAromando with new CEO Kelly and updates fromGalderma JadeOutlookAvacta andZura"  
![@BioCentury Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::227778014.png) [@BioCentury](/creator/x/BioCentury) on [X](/post/tweet/1940221418089623563) 2025-07-02 01:30:08 UTC 16.2K followers, XXX engagements


"Sino Biopharma acquires Lanova in rare China-China takeout. Plus AbbVie pays $700M up front for trispecific mAb in development formultiple myeloma in BioCentury's latest deals report"  
![@BioCentury Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::227778014.png) [@BioCentury](/creator/x/BioCentury) on [X](/post/tweet/1945279766296215732) 2025-07-16 00:30:12 UTC 16.2K followers, XXX engagements


"Biotech venture financing fell in 1H25 both in dollars raised and number of rounds: a BioCentury Data Byte"  
![@BioCentury Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::227778014.png) [@BioCentury](/creator/x/BioCentury) on [X](/post/tweet/1945627055279800750) 2025-07-16 23:30:12 UTC 16.2K followers, 1344 engagements


"Seed/Series A money up in 1H25 but mostly a few companies raising monster rounds: a BioCentury Data Byte"  
![@BioCentury Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::227778014.png) [@BioCentury](/creator/x/BioCentury) on [X](/post/tweet/1946291423717863789) 2025-07-18 19:30:10 UTC 16.2K followers, XXX engagements


"Science Spotlight:Targeting VISTA to improve radiotherapy. BioCenturys translational roundup also includes a new glycosylation enzyme a multi-modal vaccine strategy and nine papers with links to neurology companies"  
![@BioCentury Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::227778014.png) [@BioCentury](/creator/x/BioCentury) on [X](/post/tweet/1945634612102779222) 2025-07-17 00:00:14 UTC 16.2K followers, XXX engagements


"BioCentury's latest management tracks: Stumpe an alum of Tempus and Google named chief tech officer at Danaher. Plus: Updates from Cardiff Regenics X-chem"  
![@BioCentury Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::227778014.png) [@BioCentury](/creator/x/BioCentury) on [X](/post/tweet/1938756773403296004) 2025-06-28 00:30:09 UTC 16.2K followers, XXX engagements